The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy

References

• Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: Current status and issues of interest Int J Radiat Oncol Biol Phys 2001;51:880–914.
   PubMed Web of Science ®Google Scholar
• Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Pachani AR, Webb S, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2000; 48: 649–56
   PubMed Web of Science ®Google Scholar
• Jani AB, Su A, Milano MT. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: Analysis of acute toxicity. Urology 2006; 67: 147–51
   PubMed Web of Science ®Google Scholar
• Muren LP, Redpath AT, McLaren D, Mclaren D, Rorvik J, Halvorsen OJ, et al. A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. Radiother Oncol 2006; 80: 98–105
   PubMed Web of Science ®Google Scholar
• Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach III M. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2006; 66: 654–62
   PubMed Web of Science ®Google Scholar
• Sengeløv L, von der Maase H. Radiotherapy in bladder cancer. Radiother Oncol 1999; 52: 1–14
   PubMed Web of Science ®Google Scholar
• Fokdal L, Høyer M, von der Maase H. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Acta Oncol 2004; 43: 749–57
   PubMed Web of Science ®Google Scholar
• Fokdal L, Høyer M, Meldgaard P, von der Maase H. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol 2004; 72: 139–45
   PubMed Web of Science ®Google Scholar
• Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003; 69: 291–304
   PubMed Web of Science ®Google Scholar
• Fokdal L, Honore H, Høyer M, Meldgaard P, Fode K, von der Maase H. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys 2004; 59: 436–44
   PubMed Web of Science ®Google Scholar
• Redpath AT, Muren LP. CT-guided intensity-modulated radiotherapy for bladder cancer: Isocentre shifts, margins and their impact on target dose. Radiother Oncol 2006; 81: 276–83
   PubMed Web of Science ®Google Scholar
• Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997; 24: 103–10
   PubMed Web of Science ®Google Scholar
• Hysing LB, Skorpen TN, Alber M, Fjellsbø LB, Helle SI, Muren LP. On the influence of organ motion on conformal versus intensity-modulated pelvic radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2008; 71: 1496–1503
   PubMed Web of Science ®Google Scholar
• Roeske JC, Bonta D, Mell LK, Lujan AE, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol 2003; 69: 201–7
   PubMed Web of Science ®Google Scholar
• Söhn M, Yan D, Liang J, Meldolesi E, Vargas C, Alber M. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys 2007; 67: 1066–73
   PubMed Web of Science ®Google Scholar
• Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ulrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: Dosimetric results. Int J Radiat Oncol Biol Phys 2003; 56: 573–85
   PubMed Web of Science ®Google Scholar
• Dice LR. Measures of the amount of ecologic association between species. Ecology 1945; 26: 297–302
   Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341–6
   PubMed Web of Science ®Google Scholar
• Koper PCM, Stroom JC, van Putten WLJ, Korevaar A, Gert A, Heijmen BJM, et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomized study. Int J Radiat Oncol Biol Phys 1999; 43: 727–34
   PubMed Web of Science ®Google Scholar
• Knap MM, Lundbeck F, Overgaard J. The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer. Eur J Cancer 2003; 39: 604–13
   PubMed Web of Science ®Google Scholar
• Muren LP, Wasbø E, Helle SI, Hysing LB, Karlsdottir A, Odland OH, et al. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: Planning procedures and early experiences. Int J Radiat Oncol Biol Phys 2008; 71: 1034–1041
   PubMed Web of Science ®Google Scholar
• Ashman J, Zelefsky M, Hunt M, Leibel SA, Fuks Z. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63: 765–71
   PubMed Web of Science ®Google Scholar
• Park CS, Kim Y, Lee N, Bucci KM, Quivey JM, Verhey CJ, et al. Method to account for dose fractionation in analysis of IMRT plans: Modified equivalent uniform dose. Int J Radiat Oncol Biol Phys 2005; 62: 925–32
   PubMed Web of Science ®Google Scholar
• Tonoli S, Bertoni F, De Stefani A, Vital E, De Tomasi D, Caraffini B, et al. Radical radiotherapy for bladder cancer: Retrospective analysis of a series of 459 patients treated in an Italian institution. Clin Oncol 2006; 18: 52–9
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Baier K, Richter A et al Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? Radiat Oncol 2008; Article No. 3.
   Web of Science ®Google Scholar
• Hysing LB, Kvinnsland Y, Lord H, Muren LP. Planning organ at risk volume margins for organ motion of the intestine. Radiother Oncol 2006; 80: 349–54
   PubMed Web of Science ®Google Scholar
• Burridge N, Amer A, Marchant T, Sykes J, Stratford J, Henry A, et al. Online adaptive radiotherapy of the bladder: Small bowel irradiated-volume reduction. Int J Radiat Oncol Biol Phys 2006; 66: 892–7
   PubMed Web of Science ®Google Scholar
• Pos FJ, Hulshof M, Lebesque J, Lots H, Van Tienhoven G, Moonen L, et al. Adaptive radiotherapy for invasive bladder cancer: A feasibility study. Int J Radiat Oncol Biol Phys 2006; 64: 862–8
   PubMed Web of Science ®Google Scholar